{
  "openalex_id": "W2962953235",
  "doi": "https://doi.org/10.1016/j.ejim.2019.07.009",
  "title": "North America anticoagulation forum guidance on reversal of direct oral anticoagulants",
  "abstract": "",
  "authors": [
    {
      "display_name": "William Gansheng Shi",
      "id": "A5035913292",
      "orcid": "https://orcid.org/0000-0003-0495-6432",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "William Gansheng Shi"
    },
    {
      "display_name": "Mark Crowther",
      "id": "A5079941141",
      "orcid": "https://orcid.org/0000-0003-4986-4873",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mark Crowther"
    }
  ],
  "publication_year": 2019,
  "publication_date": "2019-07-22",
  "type": "editorial",
  "cited_by_count": 6,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S138083468",
    "display_name": "European Journal of Internal Medicine",
    "issn_l": "0953-6205",
    "issn": [
      "0953-6205",
      "1879-0828"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320990"
  },
  "volume": "67",
  "issue": null,
  "first_page": "30",
  "last_page": "32",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.95799273
    },
    {
      "id": "C2778661090",
      "display_name": "Rivaroxaban",
      "level": 4,
      "score": 0.899539
    },
    {
      "id": "C2778810321",
      "display_name": "Dabigatran",
      "level": 4,
      "score": 0.8647984
    },
    {
      "id": "C2780638905",
      "display_name": "Apixaban",
      "level": 5,
      "score": 0.85702115
    },
    {
      "id": "C2780290652",
      "display_name": "Edoxaban",
      "level": 5,
      "score": 0.8361356
    },
    {
      "id": "C2776413415",
      "display_name": "Idarucizumab",
      "level": 5,
      "score": 0.77442914
    },
    {
      "id": "C2777091921",
      "display_name": "Prothrombin complex concentrate",
      "level": 4,
      "score": 0.6105852
    },
    {
      "id": "C177713679",
      "display_name": "Intensive care medicine",
      "level": 1,
      "score": 0.49899125
    },
    {
      "id": "C2776301958",
      "display_name": "Warfarin",
      "level": 3,
      "score": 0.39512506
    },
    {
      "id": "C98274493",
      "display_name": "Pharmacology",
      "level": 1,
      "score": 0.34312266
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.20933676
    },
    {
      "id": "C2779161974",
      "display_name": "Atrial fibrillation",
      "level": 2,
      "score": 0.13247585
    }
  ],
  "topics": [
    {
      "id": "T10065",
      "display_name": "Atrial Fibrillation Management and Outcomes",
      "score": 0.9995
    },
    {
      "id": "T10285",
      "display_name": "Venous Thromboembolism Diagnosis and Management",
      "score": 0.9885
    },
    {
      "id": "T12352",
      "display_name": "Heparin-Induced Thrombocytopenia and Thrombosis",
      "score": 0.9277
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1016/j.ejim.2019.07.009",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:30:17.309568",
  "source_database": "OpenAlex"
}